These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

33 related articles for article (PubMed ID: 38517352)

  • 21. Structural studies of amyloid-β peptides: Unlocking the mechanism of aggregation and the associated toxicity.
    Aleksis R; Oleskovs F; Jaudzems K; Pahnke J; Biverstål H
    Biochimie; 2017 Sep; 140():176-192. PubMed ID: 28751216
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structural polymorphism and cytotoxicity of brain-derived β-amyloid extracts.
    Al Adem K; Lee S
    Protein Sci; 2023 May; 32(5):e4639. PubMed ID: 37051675
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Photosensitizing materials and platforms for light-triggered modulation of Alzheimer's β-amyloid self-assembly.
    Lee BI; Chung YJ; Park CB
    Biomaterials; 2019 Jan; 190-191():121-132. PubMed ID: 30447644
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Perspective for Molecular Dynamics Simulation Studies of Amyloid-β Aggregates.
    Okumura H
    J Phys Chem B; 2023 Dec; 127(51):10931-10940. PubMed ID: 38109338
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Natural flavonoid hesperetin blocks amyloid β-protein fibrillogenesis, depolymerizes preformed fibrils and alleviates cytotoxicity caused by amyloids.
    Dong Q; Cui Z; Wu X; Li L; Lu F; Liu F
    Food Funct; 2024 Apr; 15(8):4233-4245. PubMed ID: 38517352
    [TBL] [Abstract][Full Text] [Related]  

  • 26. β-sheet interfering molecules acting against β-amyloid aggregation and fibrillogenesis.
    Francioso A; Punzi P; Boffi A; Lori C; Martire S; Giordano C; D'Erme M; Mosca L
    Bioorg Med Chem; 2015 Apr; 23(8):1671-83. PubMed ID: 25769517
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The development of preventives and therapeutics for Alzheimer's disease that inhibit the formation of beta-amyloid fibrils (fAbeta), as well as destabilize preformed fAbeta.
    Ono K; Naiki H; Yamada M
    Curr Pharm Des; 2006; 12(33):4357-75. PubMed ID: 17105432
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mechanistic Insight into the Design of Chemical Tools to Control Multiple Pathogenic Features in Alzheimer's Disease.
    Han J; Du Z; Lim MH
    Acc Chem Res; 2021 Oct; 54(20):3930-3940. PubMed ID: 34606227
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Exploring the Potential of Therapeutic Agents Targeted towards Mitigating the Events Associated with Amyloid-β Cascade in Alzheimer's Disease.
    Behl T; Kaur I; Fratila O; Brata R; Bungau S
    Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33050199
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Natural Products Targeting Amyloid Beta in Alzheimer's Disease.
    Lee JH; Ahn NH; Choi SB; Kwon Y; Yang SH
    Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33652858
    [TBL] [Abstract][Full Text] [Related]  

  • 31.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 32.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 33.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 2.